GRADING OF REJECTION IN PANCREAS ALLOGRAFTS Are changes needed? Cinthia B. Drachenberg, M.D. University of Maryland School of Medicine Baltimore MD.

Slides:



Advertisements
Similar presentations
Defining Preimplantation Renal Allograft Quality Is biopsy: helpful or harmful? Michael J. Goldstein MD Director, Kidney/Pancreas Transplantation RMTI/Mount.
Advertisements

Immunology of Renal Transplant
Dr. Gehan Mohamed Dr. Abdelaty Shawky
Significance of the total i-score
Tuesday Case Conference May Biopsy finding LM –Glomeruli are normal in size to mildly enlarged Mild enlargement of the mesangial areas with occasional.
Al-Qassim University Faculty of Medicine Phase II – Year III GIT Block (CMD332) EXOCRINE PANCREASE Lecture Dr. Gamal Hamra Wednesday 01/12/1430 (18/11/2009)
The Value of Zero-Hour Implantation Biopsies Volker Nickeleit Nephropathology Laboratory, Department of Pathology The University of North Carolina, Chapel.
Banff 2001 Liver Group Discussions. 1. Rejection 2.Centrilobular (zone 3) inflammatory lesions 3.Changes in late post-transplant biopsies Banff
Prolonged Diabetes Reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates Hering et al, Nature.
C4d staining and morphology in protocol biopsies Michael Mengel* For the ESPRIT-Group European Study Group For Protocol Biopsies In Renal Transplantation.
POLYOMAVIRUS INFECTION IN RENAL ALLOGRAFTS: PROGRESS SINCE BANFF 1999 Parmjeet Randhawa Associate Professor Division of Transplantation Pathology Department.
BANFF SCHEMA FOR GRADING PANCREAS ALLOGRAFT REJECTION
Slide 1PUBLICATIONS Racusen/Solez meeting report for AJT. Racusen/Solez meeting report for AJT. Manuscript on antibody-mediated rejection. Manuscript on.
Pancreas Transplant Pathology: A Surgeon’s Perspective Jon Odorico M.D., F.A.C.S. University of Wisconsin-Madison.
Pancreas Transplant Pathology: Controversial Lesions Lois J. Arend PhD, MD University of Cincinnati Department of Pathology.
Jeremy Chapman Westmead Hospital, Sydney CMV Infection and Allograft Rejection : Are we missing the point?
Sum Scores & Components’ Scores Chronic Scores Acute Rejection Scores Lillian W. Gaber University of Tennessee.
Calcineurin Inhibitor Toxicity In Kidney Allograft Protocol Biopsies Neeraja Kambham M.D. Stanford University.
Banff 2003 Liver Session Summary. Distribution of Banff Severity of Acute Rejection Graft Failure from Acute or Chronic Rejection 575/901 patients 64%
The Banff Classification: Slide Seminar Kim Solez, M.D.
Donor Organ Selection Criteria: What is Ideal? A Consensus (?) Discussion.
HISTOPATHOLOGY OF PANCREAS TRANSPLANTATION
Slide Seminar Drugs and Kidney Case 3 Heinz Regele Department of Pathology.
Sum Scores and Scores of Individual Components in Clinical Practice and Clinical Trials Lillian W. Gaber University of Tennessee.
BACKGROUND ON PANCREAS HISTOLOGICAL FINDINGS: University of Maryland experience John C. Papadimitriou, M.D.,Ph.D. Professor of Pathology.
Lesley Stevens MD Tufts-New England Medical Center
Prostate Needle Biopsy: The Pitfalls and the Role of the Pathologist – Patient Track Prostate Cancer Symposium “Intriguing Cases / Emerging Strategies.
The Role of Pancreas Transplantation in the Long Term Management of Diabetes Christopher Johnson MD Professor of Surgery Division of Transplant Surgery.
Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.
Pancreatic and Islet Cell Transplantation. GENERAL PRINCIPLES Pancreas graft survival rates have significantly improved over the past decade, and now.
Renal Transplantation for HIV/HCV Co-infected Patients Solid Organ Transplantation and People With HIV: Ethics and Policy Conference David Oldach & Robert.
This is the most comprehensive compilation of epidemiological information on Hepatitis C Graciously provided by the University Hepatitis Center (last updated.
Renal Transplantation Basic Science Review 11/23/05.
Monitoring HLA-specific antibodies
Role of CT in acute pancreatitis Consultant radiologist Riyadh Military Hospital Dr. Ahmed Refaey.
Evaluation of Liver Histology in Clinical Trials for Chronic Viral Hepatitis Zachary Goodman, M.D., Ph.D. Chief, Hepatic Pathology Armed Forces Institute.
Hepatitis C+ Recipients: Considerations for Exclusion Emily A. Blumberg, M.D.
Pathology of Kidney and the Urinary tract
Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.
Professor of Pathology, Microbiology, and Medicine
Severe vascular lesions and poor functional outcome
Interactive Case Discussion Case 6 Dr Megha S Uppin Asst Prof Dept of Pathology Nizam’s Institute of Medical Sciences Hyderabad.
The only end-points of therapy that matter are mucosal healing, normal blood work, and negative radiologic studies. Robert N. Baldassano, MD Colman Family.
Pathology of Kidney and the Urinary tract Dr. Amar C. Al-Rikabi Dr. Hala Kasouf Kfouri.
RAPAMUNE ® TM 1 Randomization Variable Day* to Day 386 Randomization Variable Day* to Day 386 RAPA, C min, TN0.765 CsA, C min, TN0.201 Gender0.117 Increasing.
Transplantation in the Diabetic Patient The Status of Pancreas transplantation A. Osama Gaber Professor of Surgery Director of the Transplant Institute,
Prognostic significance of C4-positive vs. negative rejection Heinz Regele Heinz Regele Department of Pathology Innsbruck Medical University Heinz Regele.
Faisal Al-Saif MBBS, FRCSC, ABS. - Acute Pancreatitis - Chronic Pancreatitis - Pancreatic Tumors - Pancreas Transplant.
Transplantation in HIV Michelle Roland, MD Assistant Professor of Medicine UCSF Positive Health Program at SFGH.
C4d in pancreas transplant biopsies: the Leiden experience Ingeborg Bajema Ingeborg Bajema Ingeborg Bajema.
BK Polyoma Virus: A Mini Tutorial Joel C Reynolds, MD Walter Reed Army Medical Center Nephrology Service.
David E. Kleiner, M.D., Ph.D Staff Surgical Pathologist, Laboratory of Pathology, NCI (1992-Present) Hepatic Pathologist –Collaborations with Dr. Jay Hoofnagle.
Pancreatic Tumors in Children Presented by Damien W. Carter, MD.
Erlotinib plus Gemcitabine Compared with Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute.
Pathology of Renal Transplantation
Liver transplantation for HCV infection R3 양 인 호 /Prof 김 병 호.
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
Nephrology R4 이홍주 / prof. 임천규. J Clin Pathol 2009;62:505–515.
The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant Apr;9(4):812-9.
HCV & liver transplantation
Relationship between CMV & PU disease
Walter Reed Army Medical Center
Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients  Xin Bai,
a b c d e Supplemental figure 4
Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients  Xin Bai,
Transplantation Immunology
Chapter 5: Renal Allograft Biopsy Wong Hin Seng
Transplantation Immunology
Volume 69, Issue 9, Pages (May 2006)
Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.
Presentation transcript:

GRADING OF REJECTION IN PANCREAS ALLOGRAFTS Are changes needed? Cinthia B. Drachenberg, M.D. University of Maryland School of Medicine Baltimore MD

PANCREAS TRANSPLANTATION BACKGROUND  Insulin dependent diabetics (low C- peptide).  13,000 pancreas transplants ( ).  1200 in the USA in 1998.

PANCREAS TRANSPLANTATION BACKGROUND  1y patient survival 95%  1y pancreas graft function 85%  1y kidney graft function (SPK) 91% Gruessner and Sutherland in: Clinical Transplants 1999, Cecka and Terasaki Eds. UCLA Immunogenetics Center, Los Angeles CA.

PANCREAS TX NEEDLE BX BACKGROUND  10 years since Allen et al. described the percutaneous biopsy technique (Transplantation 1991;51:1213).  > 550 done at the Univ. of MD  Complications 2-3%.

PANCREAS TX NEEDLE BX: INDICATIONS  INCREASE IN SERUM AMYLASE/ LIPASE  HYPERGLYCEMIA  UNEXPLAINED FEVER  (DECREASE IN URINARY AMYLASE)

PANCREAS TX NEEDLE BX BACKGROUND  Minimum tissue amount adequate for diagnosis in a needle biopsy: Two lobules with associated septal tissue (arteries,veins, ducts).  H&E stained sections x3  Unstained slides

GRADING: ACUTE REJECTION  Acute rejection starts in the septal area with venous endotheliitis. Vessels, acini and ducts are typically involved. (Carpenter et al. Sequential histopathologic changes in pancreaticoduodenal allograft rejection in dogs. Transplantation 1989; 48:764)

GRADING: ACUTE REJECTION 0 No inflammation IMinimal septal inflammation IIVenous endotheliitis IIIAcinar inflammation IVArterial endotheliitis VTransmural arteritis Drachenberg et al.: Transplantation 1997;63:1579.

GRADING OF REJECTION IN PANCREAS ALLOGRAFTS Are changes needed?

 Grade I is non-specific with equal significance as grade 0.  Simplification of the 5 grade system is desirable.  The findings in pancreas rejection appear to be analogous to rejection Types I, II and III in the kidney.

PROPOSED GRADING SCHEME 0 No inflammationNo rejection IMinimal septal infl. IIVenous endotheliitisType IA IIIAcinar inflammationType IB IVArterial endotheliitisType II VTransmural arteritisType III

Correlation with response to treatment: 212 bx, 100 pt TYPE # Treated CS CS/AL /13 (33%) 4/1(25%) I A (94%) 13 (85%) B (80%) 38 (74%) II A (0%) 12 (78%) III (12.5%)

PANCREAS NEEDLE BIOPSIES Differential Diagnosis  Acute rejection  Hyperacute rejection  Pancreatitis – peripancreatitis  Ischemia - thrombosis  Viral infections (CMV, EBV-PTLD)  Drug toxicity  Recurrence of autoimmune disease  Chronic rejection

GRADING OF CHRONIC REJECTION IN NEEDLE BIOPSIES  We had previously proposed a 5 point histological grading scheme for the diagnosis of CR in pancreas transplant needle biopsies. (Papadimitriou et al.Trans. Pro. 1999, 31,614)

GRADING OF CHRONIC REJECTION IN NEEDLE BIOPSIES  PROGRESSIVE FIBROSIS.  PROPORTIONAL ACINAR ATROPHY  TRANSPLANT ARTERIOPATHY*

UPDATED CR GRADING SCHEME  CR 0: No fibrosis  CR I: Mild, Septal fibrosis in <30% of core surface.  CR II: Moderate, Fibrosis in 30-60% of core surface.  CR III: Severe, Fibrosis in >60% of core surface. Acinar atrophy is proportional to fibrosis. Transplant arteriopathy depending on sample.

UPDATED CR SCHEME: CLINICAL CORRELATION The average time from Bx to graft failure per grade:  CR 0: 41 months  CRI: 22.3 months  CII: 10.8 months  CIII: 1.2 m (p=.0001).

UPDATED CR SCHEME: REPRODUCIBILITY 130 biopsies (Bx) from 36 randomly selected patients were analyzed blindly by 3 pathologists  CR 0: k=.94 (p.0001)  CRI: k=.79 (p.0001)  CII: k=.85 (p.0001)  CIII: k=.94 (p.0001)

UPDATED CR GRADING SCHEME The proposed scheme correlates well with graft outcome and predicts to a large extent the remaining time of graft function. The system is based on easily reproducible criteria.